Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Introduction to Fibroblasts

Introduction to Fibroblasts

Rudolph Virchow discovered spindle-shaped cells called fibroblasts in 1858. Inactive fibroblasts, called fibrocytes, become activated by various stimuli, such as growth factors and inflammatory cytokines. Activated fibroblasts play a crucial role in wound healing, inflammation, formation of new blood vessels, and cancer progression. Uncontrolled activation of fibroblasts results in fibrosis, the excess deposition of fibrous tissue, which can lead to scarring and affect normal organs. This...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Multi-stakeholder perspectives on models of in-person and remote cochlear implant aftercare and the opportunities and challenges for change.

International journal of audiology·2026

Same author

Senescence intensifies bleomycin-induced injury in idiopathic pulmonary fibrosis lung epithelial cells.

ERJ open research·2026

Same author

Breaking with convention: the role of lymphocytes in IPF.

Thorax·2026

Same author

Pirfenidone Reduces Intracochlear Fibrosis Caused by Cochlear Implantation in a Guinea Pig Model.

International journal of molecular sciences·2026

Same author

Understanding Otitis Media Among Aboriginal Children in the Kimberley Region of Western Australia: An Opportunity to Improve Health Outcomes.

Journal of paediatrics and child health·2026

Same author

Is targeted cytomegalovirus testing of infants feasible in Western Australia? An observational study.

BMJ public health·2026

Same journal

RETRACTED: Bakshi et al. Crocin Inhibits Angiogenesis and Metastasis in Colon Cancer via TNF-α/NF-kB/VEGF Pathways. <i>Cells</i> 2022, <i>11</i>, 1502.

Cells·2026

Same journal

Correction: Verde et al. Molecular Mechanisms of Protein Aggregation in ALS-FTD: Focus on TDP-43 and Cellular Protective Responses. <i>Cells</i> 2025, <i>14</i>, 680.

Cells·2026

Same journal

Inflammation in Cardiomyopathies: Cellular Mechanisms Across Cardiac Phenotype.

Cells·2026

Same journal

IL-4/IL-13-Driven Dysregulation of Epidermal Lipid Metabolism in Atopic Dermatitis: An Immunometabolic Link Between Type 2 Inflammation and Barrier Dysfunction.

Cells·2026

Same journal

Activity of DNA- and RNA-Guided Prokaryotic Argonautes in Human Mitochondria.

Cells·2026

Same journal

Placental Pathophysiology in Maternal Psychoactive Substance Use: Biological, Clinical, and Forensic Perspectives.

Cells·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 19, 2026

A Protocol for Decellularizing Mouse Cochleae for Inner Ear Tissue Engineering

A Protocol for Decellularizing Mouse Cochleae for Inner Ear Tissue Engineering

Published on: January 1, 2018

Understanding the Mechanisms Driving Fibrosis Following Cochlear Implantation-Lessons from Other Tissues.

Cecilia M Prêle^1,2, Kady J Braack^2,3, Marcus Atlas^4,5

¹School of Medical, Molecular and Forensic Sciences, Murdoch University, Murdoch, WA 6150, Australia.

|December 10, 2025

Summary

This summary is machine-generated.

Pharmacological interventions may limit cochlear implant-induced fibrosis and neo-ossification. This review explores drug candidates targeting fibrotic pathways, drawing lessons from other organs for cochlear applications.

Keywords:

anti-fibrotic cochlear implant fibrosis foreign body response neo-ossification scarring

More Related Videos

Cochlear Implant Surgery and Electrically-evoked Auditory Brainstem Response Recordings in C57BL/6 Mice

Cochlear Implant Surgery and Electrically-evoked Auditory Brainstem Response Recordings in C57BL/6 Mice

Published on: January 9, 2019

Author Spotlight: Advancements in Impedance Monitoring for Cochlear Implant Surgery

Author Spotlight: Advancements in Impedance Monitoring for Cochlear Implant Surgery

Published on: August 4, 2023

Related Experiment Videos

Last Updated: Jun 19, 2026

A Protocol for Decellularizing Mouse Cochleae for Inner Ear Tissue Engineering

A Protocol for Decellularizing Mouse Cochleae for Inner Ear Tissue Engineering

Published on: January 1, 2018

Cochlear Implant Surgery and Electrically-evoked Auditory Brainstem Response Recordings in C57BL/6 Mice

Cochlear Implant Surgery and Electrically-evoked Auditory Brainstem Response Recordings in C57BL/6 Mice

Published on: January 9, 2019

Author Spotlight: Advancements in Impedance Monitoring for Cochlear Implant Surgery

Author Spotlight: Advancements in Impedance Monitoring for Cochlear Implant Surgery

Published on: August 4, 2023

Area of Science:

Otolaryngology
Regenerative Medicine
Pharmacology

Background:

Cochlear implants restore hearing but outcomes vary due to post-surgical fibrosis and neo-ossification.
Fibrosis increases impedance, causes hearing loss, and complicates reimplantation.
Current treatments focus on steroids, but broader pharmacological options are needed.

Purpose of the Study:

To review potential drug candidates for limiting cochlear implant-induced fibrosis and neo-ossification.
To identify molecular and cellular mechanisms driving cochlear fibrosis.
To adapt therapeutic strategies from other organs to the cochlea.

Main Methods:

Literature review of pharmacological interventions for fibrosis in various organs.
Analysis of fibrotic pathways including TGF-β/SMAD, PDGF, and Wnt/β-catenin.
Evaluation of anti-inflammatory signaling pathways.

Main Results:

Identified drug candidates targeting core fibrotic pathways and pro-inflammatory signaling.
Highlighted transferable mechanisms and therapeutic approaches from other tissues.
Emphasized the need to consider local delivery, ototoxicity, and electrode-tissue interface effects.

Conclusions:

Understanding cross-organ fibrotic mechanisms can guide strategies for cochlear fibrosis.
Pharmacological interventions offer promising avenues to improve cochlear implant outcomes.
Careful evaluation is crucial for translating these therapies to clinical practice.